Glycorex Transplantation AB announced Mr. Erik Melgaard Pedersen as the company's Head of Sales. In this role, Mr. Pedersen will oversee all commercial activities for the company as company continue to expand globally. Mr. Pedersen will take on his responsibilities as per April 1st, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 SEK | -0.47% |
|
+1.45% | -20.75% |
1st Jan change | Capi. | |
---|---|---|
-20.75% | 7.32M | |
+8.50% | 27.03B | |
+14.77% | 2.39B | |
+21.48% | 2.37B | |
-51.12% | 2.18B | |
-32.08% | 2.03B | |
+22.22% | 1.87B | |
-18.71% | 1.71B | |
+7.30% | 1.34B | |
+27.03% | 1.27B |
- Stock Market
- Equities
- GTAB B Stock
- News Glycorex Transplantation AB
- Glycorex Transplantation AB (Publ.) Announces Appointment of Erik Melgaard Pedersen as Head of Sales, Effective April 1, 2022